Evaluation of Strategies for the Assessment of Drug–Drug Interactions Involving Cytochrome P450 Enzymes

被引：0
|
作者：
Jelle Reinen
Martijn Smit
Mira Wenker
机构：
[1] Charles River Laboratories Den Bosch B.V,
来源：
European Journal of Drug Metabolism and Pharmacokinetics | 2018年 / 43卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：737 / 750
页数：13
相关论文
共 50 条
  • [21] A reference tool for cytochrome P450 drug interactions
    Waterworth C.
    Critical Care, 4 (1):
  • [22] The role of cytochrome P450 in antiretroviral drug interactions
    Walubo, Andrew
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2007, 3 (04) : 583 - 598
  • [23] Cytochrome P450 drug interactions with statin therapy
    Goh, Ivanna Xin Wei
    How, Choon How
    Tavintharan, Subramaniam
    SINGAPORE MEDICAL JOURNAL, 2013, 54 (03) : 131 - 135
  • [24] Metabolism and Interactions of Chloroquine and Hydroxychloroquine with Human Cytochrome P450 Enzymes and Drug Transporters
    Rendic, Slobodan P.
    Guengerich, F. Peter
    CURRENT DRUG METABOLISM, 2020, 21 (14) : 1127 - 1135
  • [25] The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes
    Mikov, Momir
    Danic, Maja
    Pavlovic, Nebojsa
    Stanimirov, Bojan
    Golocorbin-Kon, Svetlana
    Stankov, Karmen
    Al-Salami, Hani
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (06) : 881 - 890
  • [26] Cytochrome P450 Enzymes as Drug Targets in Human Disease
    Guengerich, F. Peter
    DRUG METABOLISM AND DISPOSITION, 2024, 52 (06) : 493 - 497
  • [27] The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes
    Momir Mikov
    Maja Đanić
    Nebojša Pavlović
    Bojan Stanimirov
    Svetlana Goločorbin-Kon
    Karmen Stankov
    Hani Al-Salami
    European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 881 - 890
  • [28] Cytochrome P450 enzymes in drug metabolism and chemical toxicology
    Furge, LL
    Guengerich, FP
    BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION, 2006, 34 (02) : 66 - 74
  • [29] In vitro drug interactions of cytochrome P450: An evaluation of fluorogenic to conventional substrates
    Cohen, LH
    Remley, MJ
    Raunig, D
    Vaz, ADN
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (08) : 1005 - 1015
  • [30] Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions
    Obach, R. Scott
    Walsky, Robert L.
    Venkatakrishnan, Karthik
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (02) : 246 - 255
12345